Stem Pharm is a neurologic drug discovery platform company using a human-first approach. Our patented platform is based on human stem cell derived 3D neural models (i.e. brain organoids) that uniquely incorporate microglia, the brain’s resident immune cells. That provides the ability to model neuroinflammation which plays a critical role in neurologic diseases. By combining the power to model complex human neural biology with a rich set of analytical tools, we can uncover and validate novel targets with more translatability than previously available. We are developing our therapeutic pipeline through pharma collaborations and internal developments. We are currently engaged in multiple paid pilot studies with pharma companies and our internal pipeline is focused on Temporal Lobe Epilepsy, Alzheimer’s Disease, and Glioblastoma.